| Updated:
FTSE flat despite Oxford jab approval giving cause for 2021 optimism
The FTSE 100 nibbled upward in early trading but fell to flat by lunchtime, as traders looked forward with some optimism to 2021.
The index gained Tuesday, with many stocks hitting pre-pandemic highs.
Traders were less bullish today, and after reaching gains of 0.3 per cent this morning the index has settled flat.
Read more: Could 2021 be the FTSE 100’s year?
AstraZeneca, whose Covid-19 jab was approved by UK regulators this morning, was the biggest winner in early trading, up just north of 1.5 per cent.
The DAX and the CAC-40 were largely flat this morning. Asian markets hit record highs overnight.
There is one more day of trading to go before a break for the New Year holiday in the UK.